2.91
0.08 (2.83%)
| Penutupan Terdahulu | 2.83 |
| Buka | 2.84 |
| Jumlah Dagangan | 3,700,498 |
| Purata Dagangan (3B) | 3,820,726 |
| Modal Pasaran | 656,365,120 |
| Harga / Buku (P/B) | 1.48 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2025 - 11 Aug 2025 |
| EPS Cair (TTM) | -1.16 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 40.68% |
| Nisbah Semasa (MRQ) | 3.54 |
| Aliran Tunai Operasi (OCF TTM) | -223.15 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -168.60 M |
| Pulangan Atas Aset (ROA TTM) | -31.82% |
| Pulangan Atas Ekuiti (ROE TTM) | -99.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menurun | Menurun |
| Biotechnology (Global) | Menurun | Menurun | |
| Stok | Sana Biotechnology, Inc. | Menaik | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | 3.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 2.0 |
| Purata | 0.75 |
|
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 among others. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 8.59% |
| % Dimiliki oleh Institusi | 93.73% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Flagship Pioneering Inc. | 31 Mar 2025 | 25,001,856 |
| Canada Pension Plan Investment Board | 31 Mar 2025 | 10,175,000 |
| Julat 52 Minggu | ||
| Median | 11.00 (278.01%) | |
| Jumlah | 1 Beli | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 24 Apr 2025 | 11.00 (278.01%) | Beli | 1.77 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 09 Jun 2025 | Pengumuman | Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions |
| 28 May 2025 | Pengumuman | Sana Biotechnology to Present at June 2025 Investor Conferences |
| 12 May 2025 | Pengumuman | Sana Biotechnology to Present at the BofA Securities 2025 Healthcare Conference |
| 08 May 2025 | Pengumuman | Sana Biotechnology Reports First Quarter 2025 Financial Results and Business Updates |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |